The renin-angiotensin-aldosterone system (RAAS) is a regulator of blood pressure and cardiovascular function, currently being researched due to COVID-19.

The Relation of Angiotensin-Converting Enzyme 2, Renin-Angiotensin-Aldosterone System Inhibitors, and Arterial Stiffness in Acute COVID-19 Emergency Department Patients—A Prospective ...

Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020;382:1653-1659. Crossref. PubMed. Web of Science. Google Scholar. 9. Danser AHJ, Epstein M, Batlle D ...

Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? Janice G. Douglas, MD. Disclosures. July 07, 2004. In This Article.

ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Discontinuing or reducing renin-angiotensin-aldosterone system inhibitor treatment may have negative outcomes for patients with hyperkalemia, but it is a common practice in many clinics, according ...

Background Altitude training produces advantages over sea level training, but athletes require acclimatization to avoid discomfort or mountain sickness, in which the blood pressure control is ...

Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? Janice G. Douglas, MD. Disclosures. July 07, 2004. In This Article.